Dr. Agarwals Health Care Ltd
Presentation on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, is attached.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 04 Aug 2026, 02:13 PM IST · BSE ID: 22b4e412-b048-4be5-8b6b-19287941c8ef
View Original BSE Filing (PDF)
💡
In Simple Terms
The company published its quarterly report to investors, showing higher sales and profits compared to the same period last year.
🤖 AI Summary
- Dr. Agarwals Health Care released its Q1 FY27 investor presentation, detailing financial and operational performance.
- Revenue from Operations increased 26.0% year-on-year to ₹614 Cr in Q1 FY27.
- Profit After Tax for Q1 FY27 grew 44.6% year-on-year to ₹55 Cr.
- IndAS EBITDA for Q1 FY27 was ₹177 Cr, marking a 25.2% year-on-year growth.
- The company added 16 greenfield surgical facilities and 5 primary facilities in Q1 FY27, reaching 304 total facilities.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Revenue from Operations (Q1 FY27)
₹614 Cr.
26.0%
IndAS EBITDA (Q1 FY27)
₹177 Cr.
25.2%
Profit After Tax (Q1 FY27)
₹55 Cr.
44.6%
Number of Eye Care Facilities (as of June 30, 2026)
304
Greenfield Surgical Facilities Added (Q1 FY27)
16
🏢 How This Affects the Company
The company's Revenue from Operations increased by 26.0% YoY, indicating growth in its eye care services chain. The addition of 16 greenfield surgical facilities expands its market reach and operational capacity.
Profit After Tax rose by 44.6% YoY to ₹55 Cr, while IndAS EBITDA grew by 25.2% YoY to ₹177 Cr, demonstrating improved profitability and operational efficiency.
The total number of eye care facilities reached 304 as of June 30, 2026, with 16 new surgical facilities and 5 primary facilities added in Q1 FY27, enhancing service delivery footprint.
👥 What This Means For Shareholders
✅
Action Required
No specific action required from shareholders based on this filing.
👤
Who Is Affected
Shareholders are provided with the detailed investor presentation for Q1 FY27, reflecting the company's financial and operational performance for the period.
🔍
Management Signal
The release of a comprehensive investor presentation signals management's commitment to transparency and communication of quarterly performance.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY27 unaudited financial results — confirm revenue and profit growth trends.
Update on new facility additions — track network expansion progress.
Analyst/Earnings conference call transcript — review detailed management commentary.
LOW RISK
The filing presents positive financial and operational results with no new risks identified.
💡 Investor Takeaway
Dr. Agarwals Health Care reported Q1 FY27 Revenue from Operations of ₹614 Cr, up 26.0% YoY. Profit After Tax was ₹55 Cr, a 44.6% YoY increase. IndAS EBITDA grew 25.2% YoY to ₹177 Cr. The company expanded its network, adding 16 greenfield surgical facilities and 5 primary facilities.
⚖️ Strengths & Concerns
✅ Positives
- Revenue from Operations increased 26.0% year-on-year, reaching ₹614 Cr in Q1 FY27, reflecting strong top-line growth.
- Profit After Tax grew 44.6% year-on-year to ₹55 Cr in Q1 FY27, indicating enhanced profitability and operational efficiency.
📅 Company Track Record
Dr. Agarwals Health Care reported Q1 FY27 Revenue from Operations up 26.0% YoY to ₹614 Crores and PAT up 44.6% YoY, following FY26 total income of INR 2,125 crores, which was up 20.9% YoY.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Dr. Agarwals Health Care's Revenue from Operations in Q1 FY27?
Dr. Agarwals Health Care reported Revenue from Operations of ₹614 Cr in Q1 FY27, an increase of 26.0% year-on-year.
What was the Profit After Tax for Dr. Agarwals Health Care in Q1 FY27?
The Profit After Tax for Dr. Agarwals Health Care in Q1 FY27 was ₹55 Cr, showing a 44.6% growth year-on-year.
How many facilities did Dr. Agarwals Health Care have as of June 30, 2026?
As of June 30, 2026, Dr. Agarwals Health Care operated 304 eye care facilities, including the addition of 16 greenfield surgical facilities and 5 primary facilities in Q1 FY27.
What was Dr. Agarwals Health Care's IndAS EBITDA in Q1 FY27?
Dr. Agarwals Health Care's IndAS EBITDA in Q1 FY27 was ₹177 Cr, representing a 25.2% increase year-on-year.
Questions based on this BSE filing only. For information purposes.